You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 13, 2025

Details for Patent: 10,117,867


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,117,867 protect, and when does it expire?

Patent 10,117,867 protects CAPLYTA and is included in one NDA.

This patent has twenty-one patent family members in nine countries.

Summary for Patent: 10,117,867
Title:Methods and compositions for sleep disorders and other disorders
Abstract: Use of particular substituted heterocycle fused gamma-carboline compounds as pharmaceuticals and pharmaceutical compositions comprising them for the treatment of one or more disorders involving the 5-HT2A, SERT and/or dopamine D2 pathways are disclosed. In addition, the compounds may be combined with other therapeutic agents for the treatment of one or more sleep disorders, depression, psychosis, dyskinesias, and/or Parkinson's disease or any combinations.
Inventor(s): Mates; Sharon (New York, NY), Fienberg; Allen (New York, NY), Wennogle; Lawrence P. (Hillsborough, NJ)
Assignee: INTRA-CELLULAR THERAPIES, INC. (New York, NY)
Application Number:15/467,867
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

Patents are a crucial component of innovation, protecting intellectual property and encouraging further research and development. The U.S. Patent and Trademark Office (USPTO) is the agency responsible for granting U.S. patents and registering trademarks. This article will delve into the scope and claims of U.S. patents, using the example of U.S. Patent 10,117,867, and provide a broader context of the patent landscape in the United States.

The Role of the USPTO

The USPTO is the central authority for patent and trademark matters in the United States. It is responsible for examining patent applications, granting patents, and maintaining a database of existing patents[2].

Patent Scope and Claims

Patent scope refers to the breadth and specificity of what is protected by a patent. It is often measured using metrics such as independent claim length and independent claim count. These metrics help in assessing the clarity and validity of a patent, which are critical in determining its quality[3].

Independent Claim Length and Count

Independent claims are those that stand alone and do not rely on other claims for their meaning. The length and count of these claims can indicate the complexity and breadth of the patent. Generally, narrower claims with shorter lengths are associated with a higher probability of grant and a shorter examination process[3].

Patent 10,117,867: A Case Study

To illustrate the concepts of patent scope and claims, let's consider U.S. Patent 10,117,867, though the specific details of this patent are not provided here. Here is how one might analyze it:

Claim Structure

  • Independent Claims: These are the core claims that define the invention without referencing other claims.
  • Dependent Claims: These claims build upon the independent claims, often adding additional features or limitations.

Claim Language

The language used in the claims is crucial. It must be clear and specific to avoid ambiguity and ensure that the scope of the patent is well-defined. For example, if a patent claim is overly broad, it may face challenges during the examination process or in court[3].

Technological Field

Patents are classified into various technological fields based on the World Intellectual Property Organization (WIPO) classification. This helps in understanding the broader context of the invention and its place within the existing patent landscape. For instance, patents in the electrical engineering field, which includes computer technology and digital communication, have seen significant growth in recent years[1].

Patent Trends in the United States

Industry Affiliation

The majority of patents granted by the USPTO are to businesses, with a significant portion going to firms in the computer and electronics manufacturing industry. These industries also report the highest levels of domestic R&D performance, indicating a strong correlation between R&D investment and patent activity[1].

Technological Areas

Patents can be grouped into broad technology areas such as electrical engineering, mechanical engineering, and chemistry. Electrical engineering patents, particularly those related to information and communication technologies (ICT), have seen a substantial increase over the past two decades[1].

Geographic Distribution

Patents are allocated geographically based on the inventor's location. The USPTO data shows that patents are distributed across various regions, with a significant number being granted to inventors in the United States and other major technological hubs around the world[1].

Tools for Patent Search and Analysis

Patent Public Search

The USPTO offers several tools for searching and analyzing patents, including the Patent Public Search tool, which provides enhanced access to prior art and improves the overall patent searching process[4].

Global Dossier

This service allows users to access the file histories of related applications from participating IP Offices, providing a comprehensive view of the patent family and related documentation[4].

Patent and Trademark Resource Centers (PTRCs)

These centers offer local search resources and training in patent search techniques, helping inventors and businesses navigate the complex patent landscape[4].

Challenges and Debates

Patent Quality

There is ongoing debate about the quality of patents, with concerns over the breadth and clarity of claims. Narrower claims are generally associated with higher quality patents, as they are less likely to face legal challenges and are more specific in their protection[3].

Small Claims Patent Court

There have been discussions about establishing a small claims patent court to address the high costs associated with patent litigation. This could provide a more accessible and cost-effective way for small inventors and businesses to protect their intellectual property[5].

Key Takeaways

  • Patent Scope: Measured by metrics such as independent claim length and count, it is crucial for determining the quality and validity of a patent.
  • Technological Fields: Patents are classified into various fields, with electrical engineering and ICT being significant areas of growth.
  • Industry Affiliation: Businesses, particularly those in the computer and electronics manufacturing industry, receive the majority of patents.
  • Tools for Search and Analysis: The USPTO provides several tools to facilitate patent searching and analysis.
  • Challenges and Debates: Issues such as patent quality and the need for a small claims patent court are ongoing topics of discussion.

FAQs

What is the role of the USPTO in the patent process?

The USPTO is responsible for examining patent applications, granting patents, and maintaining a database of existing patents.

How is patent scope measured?

Patent scope is often measured using metrics such as independent claim length and independent claim count.

Which industries receive the most patents in the United States?

Firms in the computer and electronics manufacturing industry receive the greatest number of patents, followed by other high R&D industries.

What tools does the USPTO provide for patent searching?

The USPTO offers tools such as the Patent Public Search, Global Dossier, and Patent and Trademark Resource Centers (PTRCs) to facilitate patent searching and analysis.

Why is there a debate about patent quality?

The debate centers around the breadth and clarity of patent claims, with narrower claims generally associated with higher quality patents.

Sources

  1. National Science Foundation, "Invention: U.S. and Comparative Global Trends," January 15, 2020.
  2. USA.gov, "U.S. Patent and Trademark Office (USPTO)."
  3. SSRN, "Patent Claims and Patent Scope," September 29, 2016.
  4. USPTO, "Search for patents."
  5. Administrative Conference of the United States, "U.S. Patent Small Claims Court."

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,117,867

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Intra-cellular CAPLYTA lumateperone tosylate CAPSULE;ORAL 209500-002 Apr 22, 2022 RX Yes No ⤷  Try for Free ⤷  Try for Free TREATMENT OF BIPOLAR DEPRESSION ⤷  Try for Free
Intra-cellular CAPLYTA lumateperone tosylate CAPSULE;ORAL 209500-003 Apr 22, 2022 RX Yes No ⤷  Try for Free ⤷  Try for Free TREATMENT OF BIPOLAR DEPRESSION ⤷  Try for Free
Intra-cellular CAPLYTA lumateperone tosylate CAPSULE;ORAL 209500-001 Dec 20, 2019 RX Yes Yes ⤷  Try for Free ⤷  Try for Free TREATMENT OF BIPOLAR DEPRESSION ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 3 of 3 entries

International Family Members for US Patent 10,117,867

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2009251816 ⤷  Try for Free
Australia 2015218433 ⤷  Try for Free
Canada 2725342 ⤷  Try for Free
China 102105059 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.